• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Bioequivalence: performance of several measures of extent of absorption.生物等效性:吸收程度的几种测量指标的表现。
Pharm Res. 1994 May;11(5):715-22. doi: 10.1023/a:1018932430733.
2
Bioequivalence: performance of several measures of rate of absorption.生物等效性:几种吸收速率测量指标的表现
Pharm Res. 1994 Jul;11(7):966-74. doi: 10.1023/a:1018970901116.
3
Evaluation of bioequivalence of highly variable drugs using clinical trial simulations. II: Comparison of single and multiple-dose trials using AUC and Cmax.使用临床试验模拟评估高变异药物的生物等效性。II:使用AUC和Cmax比较单剂量和多剂量试验。
Pharm Res. 1998 Jan;15(1):98-104. doi: 10.1023/a:1011961006297.
4
Evaluation of truncated areas in the assessment of bioequivalence of immediate release formulations of drugs with long half-lives and of Cmax with different dissolution rates.在评估具有长半衰期的速释制剂的生物等效性以及不同溶出速率的Cmax时对截短面积的评估。
Pharm Res. 1999 Jun;16(6):939-43. doi: 10.1023/a:1018898624643.
5
Absorption rate vs. exposure: which is more useful for bioequivalence testing?吸收速率与暴露量:哪一个对生物等效性测试更有用?
Pharm Res. 1996 Mar;13(3):453-6. doi: 10.1023/a:1016061013606.
6
Evaluation of different indirect measures of rate of drug absorption in comparative pharmacokinetic studies.在比较药代动力学研究中对不同药物吸收速率间接测量方法的评估。
J Pharm Sci. 1994 Feb;83(2):212-5. doi: 10.1002/jps.2600830219.
7
Use of truncated areas to measure extent of drug absorption in bioequivalence studies: effects of drug absorption rate and elimination rate variability on this metric.在生物等效性研究中使用截断面积来测量药物吸收程度:药物吸收速率和消除速率变异性对该指标的影响。
Pharm Res. 1999 Jan;16(1):130-4. doi: 10.1023/a:1018839300168.
8
Cmax/AUC is a clearer measure than Cmax for absorption rates in investigations of bioequivalence.在生物等效性研究中,对于吸收速率而言,Cmax/AUC比Cmax是更清晰的衡量指标。
Int J Clin Pharmacol Ther Toxicol. 1991 Oct;29(10):394-9.
9
Evaluation of bioequivalence of highly variable drugs using Monte Carlo simulations. I. Estimation of rate of absorption for single and multiple dose trials using Cmax.使用蒙特卡洛模拟评估高变异性药物的生物等效性。I. 使用Cmax估计单剂量和多剂量试验的吸收速率。
Pharm Res. 1995 Nov;12(11):1634-41. doi: 10.1023/a:1016288916410.
10
Computer simulations for bioequivalence trials: Selection of analyte in BCS class II and IV drugs with first-pass metabolism, two metabolic pathways and intestinal efflux transporter.用于生物等效性试验的计算机模拟:具有首过代谢、两种代谢途径和肠外排转运体的 BCS Ⅱ类和 IV 类药物中分析物的选择。
Eur J Pharm Sci. 2018 May 30;117:193-203. doi: 10.1016/j.ejps.2018.02.014. Epub 2018 Feb 13.

引用本文的文献

1
A Vector Theory of Assessing Clinical Trials: An Application to Bioequivalence.一种评估临床试验的向量理论:在生物等效性中的应用。
J Cardiovasc Dev Dis. 2024 Jun 21;11(7):185. doi: 10.3390/jcdd11070185.
2
An In Silico Approach toward the Appropriate Absorption Rate Metric in Bioequivalence.生物等效性中合适吸收速率指标的计算机模拟方法。
Pharmaceuticals (Basel). 2023 May 10;16(5):725. doi: 10.3390/ph16050725.
3
A Bayesian population physiologically based pharmacokinetic absorption modeling approach to support generic drug development: application to bupropion hydrochloride oral dosage forms.

本文引用的文献

1
A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability.两种单侧检验方法与评估平均生物利用度等效性的效能法的比较。
J Pharmacokinet Biopharm. 1987 Dec;15(6):657-80. doi: 10.1007/BF01068419.
一种支持仿制药开发的基于贝叶斯群体生理药代动力学吸收建模方法:应用于盐酸安非他酮口服剂型。
J Pharmacokinet Pharmacodyn. 2021 Dec;48(6):893-908. doi: 10.1007/s10928-021-09778-5. Epub 2021 Sep 22.
4
A Proton Pump Inhibitor in the Reformulation Setting: Bioequivalence and Potential Implications for Long-Term Safety.质子泵抑制剂在改剂型中的研究:生物等效性及对长期安全性的潜在影响。
Clin Transl Sci. 2017 Sep;10(5):387-394. doi: 10.1111/cts.12475. Epub 2017 Jun 15.
5
Simulation studies on the estimation of total area under the curve in the presence of right-tailed censoring.存在右删失情况下曲线下总面积估计的模拟研究。
J Pharmacokinet Pharmacodyn. 2015 Feb;42(1):19-32. doi: 10.1007/s10928-014-9395-8. Epub 2014 Oct 31.
6
MicroRNAs are absorbed in biologically meaningful amounts from nutritionally relevant doses of cow milk and affect gene expression in peripheral blood mononuclear cells, HEK-293 kidney cell cultures, and mouse livers.微小RNA能从具有营养相关性剂量的牛奶中以具有生物学意义的量被吸收,并影响外周血单核细胞、HEK - 293肾细胞培养物及小鼠肝脏中的基因表达。
J Nutr. 2014 Oct;144(10):1495-500. doi: 10.3945/jn.114.196436. Epub 2014 Aug 13.
7
Generic products of antiepileptic drugs: a perspective on bioequivalence, bioavailability, and formulation switches using Monte Carlo simulations.抗癫痫药物的仿制药:基于蒙特卡罗模拟的生物等效性、生物利用度和剂型转换视角。
CNS Drugs. 2014 Jan;28(1):69-77. doi: 10.1007/s40263-013-0112-8.
8
Measures of exposure versus measures of rate and extent of absorption.暴露量度与吸收速率及吸收程度量度
Clin Pharmacokinet. 2001;40(8):565-72. doi: 10.2165/00003088-200140080-00001.
9
Novel direct curve comparison metrics for bioequivalence.用于生物等效性的新型直接曲线比较指标。
Pharm Res. 2001 Jun;18(6):734-41. doi: 10.1023/a:1011067908500.
10
Evaluation of truncated areas in the assessment of bioequivalence of immediate release formulations of drugs with long half-lives and of Cmax with different dissolution rates.在评估具有长半衰期的速释制剂的生物等效性以及不同溶出速率的Cmax时对截短面积的评估。
Pharm Res. 1999 Jun;16(6):939-43. doi: 10.1023/a:1018898624643.

生物等效性:吸收程度的几种测量指标的表现。

Bioequivalence: performance of several measures of extent of absorption.

作者信息

Bois F Y, Tozer T N, Hauck W W, Chen M L, Patnaik R, Williams R L

机构信息

Indoor Environment Program, Lawrence Berkeley Laboratory, Berkeley, California 94720.

出版信息

Pharm Res. 1994 May;11(5):715-22. doi: 10.1023/a:1018932430733.

DOI:10.1023/a:1018932430733
PMID:8058642
Abstract

The determination of the area under the concentration-time curve (AUC) is the method most commonly used by regulatory agencies to assess extent of drug absorption after single-dose administration of oral products. Using simulations, several approaches toward measuring the actual area, in whole or part, were tested. In addition, the performance of the peak concentration (Cmax), usually taken as a measure of the rate of absorption was assessed evaluating extent. Model scenarios for drugs with typical mean characteristics and statistical distributions were investigated. Using different kinetic models of disposition, the time course of the drug concentration in plasma was simulated. Intraindividual and interindividual variability and assay error were modeled using Monte Carlo techniques. The accuracy, precision, and ease of use of the various measures of extent were evaluated, and statistical power analyses were performed. Among the measures tested, the most reliable were the AUC computed up to the time of the last quantifiable concentration, without extrapolation, and Cmax. However, being also sensitive to rate, Cmax as a measure of extent is of limited potential.

摘要

浓度-时间曲线下面积(AUC)的测定是监管机构评估口服产品单剂量给药后药物吸收程度最常用的方法。通过模拟,测试了几种测量全部或部分实际面积的方法。此外,评估峰浓度(Cmax)(通常作为吸收速率的指标)时,对其吸收程度进行了评估。研究了具有典型平均特征和统计分布的药物的模型场景。使用不同的处置动力学模型,模拟了血浆中药物浓度的时间过程。使用蒙特卡罗技术对个体内和个体间变异性以及分析误差进行建模。评估了各种吸收程度测量方法的准确性、精密度和易用性,并进行了统计功效分析。在所测试的测量方法中,最可靠的是在不进行外推的情况下计算至最后可量化浓度时间的AUC以及Cmax。然而,由于Cmax对速率也敏感,作为吸收程度的指标,其潜力有限。